Influence of stent design and material composition on procedure outcome

Journal of Vascular Surgery

Volumn 36, Issue 5, 2002, Pages 1031-1039

  Palmaz, Julio C ^a   Bailey, Steven ^a   Marton, Denes ^a   Sprague, Eugene ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY INTIMA PROLIFERATION; CELL MIGRATION; CHEMICAL COMPOSITION; CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DEVICE; HUMAN; INFLAMMATION; MATERIALS; MICROBIAL CONTAMINATION; PERFORMANCE; PRIORITY JOURNAL; PROSTHESIS; RESTENOSIS; REVIEW; STENT; THROMBOSIS; TREATMENT OUTCOME;

EID: 0036847067     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.129113     Document Type: Article

References (52)

1. Topol EJ. Coronary-artery stents: Gauging, gorging, and gouging. N Engl J Med 1998;339:1702-4.
2. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: Serial angiographic follow-up of 229 patients. Am J Cardiol 1988;12:616-23.
3. Serruys PW, Luijten HE, Beatt KJ, Geuskens R, de Feyter PJ, van den Brand M, et al. Incidence ofrestenosis after successful coronary angioplasty: A time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988;77:361-71.
4. Orford JL, Selwyn AP, Ganz P, Popma JJ, Rogers C. The comparative pathobiology of atherosclerosis and restenosis. Am J Cardiol 2000;86:6H-11H.
5. Kuntz RE, Gibson CM, Nobuyoshi M, Baim DS. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. Am J Cardiol 1993;21:15-25.
6. Schwartz KS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, et al. Restenosis and the proportional neointimal response to coronary, artery injury: Results in a porcine model. J Am Coll Cardiol 1992;19:267-74.
7. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, et al. Pathology of acute and chronic coronary, stenting in humans. Circulation 1999;99:44-52.
8. Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002;105:2974-80.
9. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia. Am J Cardiol 1998;31:224-30.
10. Whelan DM, van Beusekom HM, van der Giessen WJ. Foreign body contamination during stent implantation. Catheter Cardiovasc Diagn 1997;40:328-32.
11. Bayes-Genis A, Camrud AR, Jorgenson M, Donovan J, Shogren KL, Holmes DR Jr, et al. Pressure rinsing of coronary stents immediately before implantation reduces inflammation and neointimal hyperplasia. J Am Coll Cardiol 2001;38:562-8.
12. Kastrati A, Mehilli J, Dirschinger J, Pache J, Ulm K, Schuhlen H, et al. Restenosis after coronary placement of various stent types. Am J Cardiol 2001;87:34-9.
13. Taniguchi I, Yamazaki T, Wagatsuma K, Kurusu T, Shimazu Y, Takikawa K, et al. The DD genotype ofangiotensin converting enzyme polymorphism is a risk factor for coronary artery disease and coronary, stent restenosis in Japanese patients. Japn Circ J 2001;65:897-900.
14. Hicks RC, Ellis M, Mir-Hasseine R, Higman DJ, Nott D, Greenhalgh RM, et al. The influence of fibrinogen concentration on the development of vein graft stenoses. Eur J Vasc Endovasc Surg 1995;9:415-20.
15. Kastrati A, Dirschinger J, Boekstegers P, Elezi S, Schuhlen H, Pache J, et al. Influence of stent design on 1-year outcome after coronary stent placement: A randomized comparison of five stent types in 1, 147 unselected patients. Catheter Cardiovasc Interv 2000;50:290-7.
16. Wagatsuma K, Takikawa K, et al. Does stent really prevent late vessel remodeling? QCU comparison of Palmaz-Schatz, Wiktor and Gianturco-Roubin Stent. Circulation 1998;98(suppl):I-661.
17. Lansky AJ, Roubin GS, O'Shaughnessy CD, Moore PB, Dean LS, Raizner AE, et al. Randomized comparison of GR-II stent and Palmaz-Schatz stent for elective treatment of coronary stenoses. Circulation 2000;102:1364-8.
18. Escaned J, Goicolea J, Alfonso F, Perez-Vizcayno MJ, Hernandez R, Fernandez-Ortiz A, et at. Propensity and mechanisms of restenosis in different coronary stent designs: Complemental, value of the analysis of the luminal gain-loss relationship. Am J Cardiol 1999;34:1490-7.
19. Sprague EA, Luo J, Palmaz JC. Human aortic endothelial cell migration onto stent surfaces under static and flow conditions. J Vasc Interv Radiol 1997;8(1 Pt 1):83-92.
20. Simon C, Palmaz JC, Sprague EA. Influence of topography on endothelialization of stents: Clues for new designs. J Long Term Eff Med Implants 2000;10:143-51.
21. Kastrati A, Mehilli J, Dirschinger J, Dotzer F, Schuhlen H, Neumann FJ, et al. Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 2001;103:2816-21.
22. Palmaz JC, Benson A, Sprague EA. Influence of surface topography on endothelialization of intravascular metallic material. J Vasc Interv Radiol 1999;10:439-44.
23. Fuss C, Sprague EA, Bailey SR, Palmaz JC. Surface micro grooves (MG) improve endothelialization rate in vitro and in vivo. Am J Cardiol 2001;37(2 Suppl A):70A.
24. Hamuro M, Palmaz JC, Sprague EA, Fuss C, Luo J. Influence of stent edge angle on endothelialization in an in vitro model. J Vasc Interv Radiol 2001;12:607-11.
25. Garasic JM, Edelman ER, Squire JC, Seifert P, Williams MS, Rogers C. Stent and artery geometry determine intimal thickening independent of arterial injury. Circulation 2000;101:812-8.
26. Ditlea S. The trials of an artificial heart. Sci Am 2002;287:60-9.
27. Shih CC, Lin SJ, Chen YL, Su YY, Lai ST, Wu GJ, et al. The cytotoxicity of corrosion products of nitinol stent wire on cultured smooth muscle cells. J Biomed Mat Res 2000;52:395-403.
28. Shih CC, Shih CM, Chen YL, Su YY, Shih JS, Kwok CF, et al. Growth inhibition of cultured smooth muscle cells by corrosion products of 316 L stainless steel wire. J Biomed Mat Res 2001;57:200-7.
29. Wataha JC, Lockwood PE, Marek M, Ghazi M. Ability of Ni-containing biomedical alloys to activate monocytes and endothelial cells in vitro. J Biomed Mat Res 1999;45:251-7.
30. Barceloux DG. Cobalt. J Toxicol Clin Toxicol 1999;37:201-6.
31. Barceloux DG. Nickel. J Toxicol Clin Toxicol 1999;37:239-58.
32. Barceloux DG. Chromium. J Toxicol Clin Toxicol 1999;37:173-94.
33. Koster R, Vieluf D, Kiehn M, Sommerauer M, Kahler J, Baldus S, et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 2000;356:1895-7.
34. Kastrati A, Schomig A, Dirschinger J, Mehilli J, von Welser N, Pache J, et al. Increased risk of restenosis after placement of gold-coated stents: Results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation 2000;101:2478-83.
35. vom Dahl J, Haager PK, Grube E, Gross M, Beythien C, Kromer EP, et al. Effects of gold coating of coronary stents on neointimal proliferation following stent implantation. Am J Cardiol 2002;89:801-5.
36. Edelman ER, Seifert P, Groothuis A, Morss A, Bornstein D, Rogers C. Gold-coated NIR stents in porcine coronary arteries. Circulation 2001;103:429-34.
37. Sawyer, PN. The relationship between surface charge (potential characteristics) of the vascular interface and thrombosis. Ann N Y Acad Sci 1983;416:561-83.
38. Sprague EA, Palmaz JC, Simon C, Watson A. Electrostatic forces on the surface of metals as measured by atomic force microscopy. J Long Term Eff Med Implants 2000;10:111-25.
39. Thierry B, Merhi Y, Bilodeau L, Trepanier C, Tabrizian M. Nitinol versus stainless steel stents: Acute thrombogenicity study in an ex vivo porcine model. Biomaterials 2002;23:2997-3005.
40. Sheth S, Litvack F, Dev V, Fishbein MC, Forrester JS, Eigler N. Subacute thrombosis and vascular injury resulting from slotted-tube nitinol and stainless steel stents in a rabbit carotid artery model [erratum in Circulation 1996;94:2668]. Circulation 1996;94:1733-40.
41. van der Giessen WJ, Lincoff AM, Schwartz RS, van Beusekom HM, Serruys PW, Holmes DR Jr, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996;94:1690-7.
42. Whelan DM, van der Giessen WJ, Krabbendam SC, van Vliet EA, Verdouw PD, Serruys PW, et al. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart 2000;83:338-45.
43. De Scheerder I, Szilard M, Yanming H, Ping XB, Verbeken E, Neerinck D, et al. Evaluation of the biocompatibility of two new diamond-like stent coatings (Dylyn) in a porcine coronary stent model. J Invasive Cardiol 2000;12:389-94.
44. Heublein B, Pethig K, Elsayed AM. Silicon Carbide Coating N A Semiconducting Hybrid Design of Coronary Stents N A Feasibility Study. J Invasive Cardiol 1998;10:255-62.
45. Antoniucci D, Valenti R, Migliorini A, Moschi G, Trapani M, Bolognese L, et al. Clinical and angiographic outcomes following elective implantation of the Carbostent in patients at high risk ofrestenosis and target vessel failure, Catheter Cardiovasc Interv 2001;54:420-6.
46. Karam C, Fajadet J, Beauchet A, Cassagneau B, Marco J. Nine-year follow-up of balloon-expandable Palmaz-Schatz stent in patients with single-vessel disease. Catheter Cardiovasc Interv 2000;50:170-4.
47. Linnemeier TJ. On the resilience of coronary stents: Are they timeless or do they corrode [letter; comment]? Catheter Cardiovasc Interv 2000;50:175-6.
48. Palmaz JC. The 2001 Charles T. Dotter lecture: Understanding vascular devices at the molecular level is the key to progress. J Vasc Interv Radiol 2001;12:789-94.
49. De Scheerder I, Verbeken E, Van Humbeeck J. Metallic surface modification. Semin Int Cardiol 1998;3:139-44.
50. Guidoin R, Marois Y, Douville Y, King MW, Castonguay M, Traore A, et al. First-generation aortic endografts: Analysis of explanted Stentor devices from the EUROSTAR Registry. J Endovasc Ther 2000;7:105-22.
51. Heintz C, Riepe G, Birken L, Kaiser E, Chakfe N, Morlock M, et al. Corroded nitinol wires in explanted aortic endografts: An important mechanism of failure? J Endovasc Ther 2001;8:248-53.
52. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.